Premedication with the opioid analgesic butorphanol raises the threshold for ischemic preconditioning in dogs

Basic Research in Cardiology

Volumn 92, Issue 2, 1997, Pages 106-114

  Schwartz, L M ^a   Jennings, R B ^a   Reimer, K A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Heart; Infarct size limitation; Ischemic preconditioning; Myocardial ischemia; Myocardial protection

Indexed keywords

BUTORPHANOL TARTRATE; OPIATE; PENTOBARBITAL; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; ARTICLE; CONDITIONING; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY COLLATERAL CIRCULATION; COVARIANCE; DOG; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PREMEDICATION; REPERFUSION;

EID: 0030914587     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00805571     Document Type: Article

References (17)

1. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM (1995) Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Cire Res 77: 611-621
2. Gross GJ, Auchampach JA (1992) Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circulation 70: 223-233
3. 1-receptors. Circulation 86: 1310-1316
4. Haessler R, Kuzume K, Chien GL, Wolff RA, Davis RF, Van Winkle DM (1994) Anaesthetics alter the magnitude of infarct limitation by ischaemic preconditioning. Cardiovasc Res 28: 1574-1580
5. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR (1990) Myocardial protection with preconditioning. Circulation 82: 609-619
6. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136
7. Murry CE, Richard VJ, Reimer KA, Jennings RB (1990) Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66: 913-931
8. Narita M, Makimura M, FengY, Hoskins B, Ho IK (1994) Influence of chronic morphine treatment on protein kinase C activity: Comparison with hutorphanol and implication for opioid tolerance. Brain Res 650: 175-179
9. Ocaña M, Del Pozo E, Barrios M, Robles LI, Baeyens JM (1990) An ATP dependent potassium channel blocker antagonizes morphine analgesia. Eur J Pharmacol 186: 377-378
10. Pircio AW, Gylys JA, Cavanagh RL, Buyniski JP, Bierwagen ME (1976) The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic. Arch Int Pharmacodyn 220: 231-257
11. Reimer KA, Jennings RB, Cobb FR, Murdock RH Jr, Greenfield JC Jr, Becker LC, Bulkley BH, Hutchins GM, Schwartz RP Jr, Bailey KR, Passamani ER (1985) Animal models for protecting ischemic myocardium: Results of the NHLBI cooperative study. Comparison of the unconscious and conscious dog models. Circ Res 56: 651-665
12. Schultz JEJ, Hsu AK, Gross GJ (1996) Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 78: 1100-1104
13. Schultz JEJ, Rose E, Yao Z, Gross GJ (1995) Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol (Heart Circ Physiol) 268: H2157-H2161
14. Vander Heide RS, Schwanz LM, Jennings RB, Reimer KA (1995) Effect of catecholamine depletion on infarct size in dogs: Role of catecholamines in ischemic preconditioning. Cardiovasc Res 30: 656-667
15. VanderHeide RS, Schwanz LM, Reimer KA (1994) The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog. Cardiovasc Res 28: 1526-1532
16. Vergoni AV, Scarano A, Bertolini A (1992) Pinacidil potentiates morphine analgesia. Life Sciences 50: 135-138
17. Wild KD, Vanderah T, Mosberg HI, Porreca F (1991) Opioid & receptor subtypes are associated with different potassium channels. Eur J Pharmacol 193: 135-136